Access cutting-edge fsgs treatment through this clinical trial at a research site in Northridge. Study-provided care at no cost to qualified participants.
Quick Self-Assessment
See if you qualify for this Northridge location
Access fsgs specialists at no cost
This study follows strict safety protocols and ethical guidelines
All study-related fsgs treatment provided free
Check if you qualify for this fsgs clinical trial in Northridge, CA
No-Cost Study Care
Local to Northridge
Convenient for CA residents
Cutting-Edge Treatment
Access to innovative therapies
Expert Medical Care
Close monitoring by specialists
Possible Compensation*
For time and travel
*Compensation varies by study. Confirm details with coordinator.
DMX-200 (repagermanium) is a C-C chemokine receptor type 2 (CCR2) inhibitor that, when administered concurrently with an ARB, is designed to inhibit recruitment of monocytes implicated in the inflammatory chemokine environment of chronic disease. The purpose of this pivotal randomized double-blind study is to investigate the efficacy and safety of DMX-200 120 mg twice daily (BID) compared with placebo over a treatment period of 104 weeks in adult patients with FSGS who are being treated with an
Sponsor: Dimerix Bioscience Pty Ltd
Yes, this clinical trial (NCT05183646) has an active research site in Northridge, CA that is currently enrolling participants.
Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.
Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.
Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.
If you're searching for fsgs treatment options in Northridge, CA, this clinical trial (NCT05183646) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Northridge research site is actively enrolling participants for this clinical trial. You'll receive care from experienced fsgs specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.
Looking for more options? Browse all fsgs clinical trials near you to find additional studies recruiting in your area.
See all nephrotic syndrome clinical trials recruiting in Northridge — not just this study.
Browse Nephrotic Syndrome Trials in Northridge →